SYNGENE - Swing Trade Analysis with AI Signals
Back to List📊 Swing Trade Rating: 3.1
| Stock Code | SYNGENE | Market Cap | 16,448 Cr. | Current Price | 408 ₹ | High / Low | 761 ₹ |
| Stock P/E | 42.9 | Book Value | 115 ₹ | Dividend Yield | 0.31 % | ROCE | 12.8 % |
| ROE | 9.78 % | Face Value | 10.0 ₹ | DMA 50 | 473 ₹ | DMA 200 | 591 ₹ |
| Chg in FII Hold | -1.35 % | Chg in DII Hold | 1.21 % | PAT Qtr | 68.7 Cr. | PAT Prev Qtr | 66.2 Cr. |
| RSI | 36.5 | MACD | -18.0 | Volume | 7,98,314 | Avg Vol 1Wk | 29,25,682 |
| Low price | 381 ₹ | High price | 761 ₹ | PEG Ratio | 33.3 | Debt to equity | 0.07 |
| 52w Index | 7.05 % | Qtr Profit Var | -44.2 % | EPS | 8.22 ₹ | Industry PE | 49.5 |
Analysis: Syngene International (SYNGENE) shows weak to moderate potential for swing trading. The RSI at 36.5 indicates oversold conditions, but the MACD (-18.0) reflects bearish momentum. The current price (₹408) is well below both the 50 DMA (₹473) and 200 DMA (₹591), signaling short-term and long-term weakness. Quarterly profit declined sharply (-44.2%), and EPS is modest (₹8.22). The PEG ratio (33.3) suggests expensive valuation relative to growth. On the positive side, ROCE (12.8%) and ROE (9.78%) are decent, debt-to-equity is low (0.07), and DII holdings increased (+1.21%). However, FII holdings decreased (-1.35%), showing reduced foreign confidence.
Optimal Entry Price: Around ₹390–400, closer to support levels and oversold RSI zone.
Exit Strategy (if already holding): Consider exiting near ₹460–480 if momentum recovers, or cut losses if price falls below ₹380.
✅ Positive
- Low debt-to-equity ratio (0.07) shows financial stability.
- DII holdings increased (+1.21%), reflecting domestic investor confidence.
- ROCE (12.8%) and ROE (9.78%) indicate moderate efficiency.
⚠️ Limitation
- Quarterly profit declined sharply (-44.2%).
- PEG ratio of 33.3 suggests overvaluation relative to growth.
- Stock P/E (42.9) is slightly below industry average (49.5) but still high.
- Price below both 50 DMA and 200 DMA reflects bearish trend.
📰 Company Negative News
- Sharp decline in quarterly profits impacts sentiment.
- FII holdings decreased (-1.35%), showing reduced foreign investor confidence.
🌟 Company Positive News
- Strong domestic institutional support with DII holdings rising.
- Low debt levels provide financial resilience.
🏦 Industry
- Biotech sector PE (49.5) is higher than Syngene’s PE (42.9), making the stock relatively cheaper but still expensive given weak earnings.
- Industry supported by demand for contract research and pharma R&D, though margins remain under pressure.
📌 Conclusion
Syngene International is a weak candidate for swing trading at current levels due to declining profits, bearish technicals, and high valuation. Entry near ₹390–400 offers better risk-reward. Exit near ₹460–480 if momentum recovers, or below ₹380 to protect capital.